ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 799

Transcriptional Profiling of Cutaneous Lupus Reveals Pronounced Changes in Keratinocyte and Myeloid Lineage Expressed Genes and Demonstrates Uniquely Regulated Interferon Pathways Between Rash Subtypes

Celine C. Berthier1, Jasmine Stannard2, Emily Myers3, William Swindell4, Lori Lowe4, Tamra J. Reed5, Johann Gudjonsson4 and J. Michelle Kahlenberg6, 1Nephrology, Division of Nephrology, University of Michigan Medical Center, Ann Arbor, MI, 2Int. Medicine/Rheumatology, University of Michigan, Ann Arbor, MI, 3Internal Medicine, Rheumatology, Georgetown University, Washington, DC, 4Dermatology, University of Michigan, Ann Arbor, MI, 5Internal Medicine, Rheumatology, University of Michigan, Ann Arbor, MI, 6Internal Medicine, Division of Rheumatology, Division of Rheumatology, University of Michigan Medical Center, Ann Arbor, MI

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: Bioinformatics, cutaneous lupus, Lupus, skin and transcriptional regulation

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 8, 2015

Title: Systemic Lupus Erythematosus - Human Etiology and Pathogenesis Poster I

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Cutaneous lupus rashes can be substantial, disfiguring, and often refractory to usual lupus therapies.  Phenotypic presentation and risk of systemic lupus manifestations differs by rash subtype and pathogenic factors contributing to rash remain poorly understood.  For this study, we evaluated the transcriptional profiles of discoid lupus (DLE) and subacute cutaneous lupus (sCLE) rashes and characterized them in the context of contributing cellular populations and the unique profiles which may contribute to individual rash phenotype.

Methods: Formalin-fixed paraffin-embedded (FFPE) tissue blocks of 26 DLE and 27 sCLE rash biopsies were acquired from the University of Michigan Anatomic Pathology repository.  RNA was isolated from five 10 micron sections and analyzed via Affymetrix ST 2.1 array.  Gene expression changes were compared to 7 similarly treated and isolated healthy control biopsies.  Genomatix, Ingenuity and in silico immunophenotyping were used for data analysis.

Results: Using q-value of <0.01 and|log Fold Change|>1 as filters, we identified 394 genes commonly upregulated and 175 genes commonly downregulated in sCLE and DLE compared to control.  Genomatix analysis confirmed enhancement of known lupus-associated pathways (especially type I interferon (IFN) regulated genes), and transcription factor analysis revealed important gene regulation by STAT1, STAT4 and IRF1.  Upregulation of TLR2 and inflammasome-associated genes were also noted.  Immunophenotypic analysis demonstrated a significant proportion of upregulated genes were likely to be derived from myeloid cells within the skin.  Alternatively, many of the downregulated genes were associated with keratinocytes.  173 genes were uniquely regulated in DLE and 116 genes were uniquely regulated in sCLE.  Unique to DLE, a strong upregulation of IFN gamma associated pathways was noted and Ingenuity pathway analysis identified IL-4 as a likely prominent regulator of DLE-specific gene expression.  In sCLE, type I IFN signaling predominated and unique expression of CD14 and the chemokines CCL20 and CCL2 were seen. 

Conclusion: These data suggest that DLE and sCLE have overlapping and unique changes which may guide pathologic phenotype.  Importantly, the role of myeloid populations in cutaneous lupus pathogenesis should be considered.  Confirmation and further study of these identified dysregulated genes may identify targets for novel therapy of cutaneous lupus lesions.


Disclosure: C. C. Berthier, None; J. Stannard, None; E. Myers, None; W. Swindell, None; L. Lowe, None; T. J. Reed, None; J. Gudjonsson, None; J. M. Kahlenberg, None.

To cite this abstract in AMA style:

Berthier CC, Stannard J, Myers E, Swindell W, Lowe L, Reed TJ, Gudjonsson J, Kahlenberg JM. Transcriptional Profiling of Cutaneous Lupus Reveals Pronounced Changes in Keratinocyte and Myeloid Lineage Expressed Genes and Demonstrates Uniquely Regulated Interferon Pathways Between Rash Subtypes [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/transcriptional-profiling-of-cutaneous-lupus-reveals-pronounced-changes-in-keratinocyte-and-myeloid-lineage-expressed-genes-and-demonstrates-uniquely-regulated-interferon-pathways-between-rash-subtype/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/transcriptional-profiling-of-cutaneous-lupus-reveals-pronounced-changes-in-keratinocyte-and-myeloid-lineage-expressed-genes-and-demonstrates-uniquely-regulated-interferon-pathways-between-rash-subtype/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology